Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Bernadette D. Asias, Eileen M. Stock, Nancy L. Small, Katerine E. Getchell, Jagruti R. Patel, Jennifer D. Krause, Staci Cavness, Cassidy L. Dzenowski, Mia Ta

ABSTRACT

BACKGROUND: Although glargine and detemir are both FDA-approved in the U.S. as long-acting insulin analogues, inherent differences in the insulins may lead to varying outcomes. This study examined changes in clinical measures and associated costs for veterans with type 2 diabetes on insulin therapy converted from insulin glargine to insulin detemir. METHODS: A retrospective before-and-after comparison study was performed at a single-site medical center located in the southwestern U.S., comprising 133 Veterans diagnosed with type 2 diabetes receiving insulin therapy with glargine and converted to insulin detemir using a 1:1 unit dosage ratio. Patients' A1c, weight, body mass index, total daily dose, and estimated monthly insulin costs during and after conversion were compared employing Wilcoxon signed-rank tests. These measures were similarly assessed in patients at A1c goal (<7 %) prior to conversion. RESULTS: When switched from insulin glargine to insulin detemir, an increase in A1c (median of 7.7 % to 8.3 %, p < 0.01) and total daily dose (TDD: 40 to 46 units/day, p < 0.01) resulted. Monthly insulin costs decreased 19 % ($47 to $38, p < 0.01), or roughly a one-year savings of $110 per patient. An increase in A1c was similarly observed for patients at-goal prior to conversion but remained at-goal post-conversion (6.5 % to 6.7 %, p = 0.02). CONCLUSION: The increase in A1c and TDD following conversion from insulin glargine to insulin detemir suggests that glargine requires a smaller amount of units to reach the same glycemic-lowering ability compared to detemir. Despite the observed insulin cost savings associated with detemir, future studies should also determine overall costs (including indirect) and benefits associated with switching from glargine to detemir among Veteran with Type 2 diabetes. More... »

PAGES

53

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40200-015-0180-z

DOI

http://dx.doi.org/10.1186/s40200-015-0180-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051373906

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26120575


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Department of Pharmacy Services, Memorial Hermann Health Care System \u2013 Texas Medical Center, 77030, Houston, TX, USA", 
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asias", 
        "givenName": "Bernadette D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Texas A&M Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.416970.d", 
          "name": [
            "Center for Applied Health Research, Central Texas Veterans Health Care System in collaboration with Baylor Scott & White Health, 76502, Temple, TX, USA", 
            "Texas A&M Health Science Center, College of Medicine, 77807, Bryan, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stock", 
        "givenName": "Eileen M.", 
        "id": "sg:person.01051523326.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051523326.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Small", 
        "givenName": "Nancy L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Getchell", 
        "givenName": "Katerine E.", 
        "id": "sg:person.01213255011.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213255011.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Jagruti R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krause", 
        "givenName": "Jennifer D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavness", 
        "givenName": "Staci", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dzenowski", 
        "givenName": "Cassidy L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Texas Veterans Health Care System", 
          "id": "https://www.grid.ac/institutes/grid.413775.3", 
          "name": [
            "Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ta", 
        "givenName": "Mia", 
        "id": "sg:person.0720325711.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720325711.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/dmrr.989", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000421969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/dmrr.989", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000421969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/dhps.s7301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002672215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc08-9017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010475808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2007.00756.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012018782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2009.03.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014022709"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2008.11.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020313983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2001.00546.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023578358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc09-2294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024449511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/458104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026481274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1478-7547-4-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030421412", 
          "https://doi.org/10.1186/1478-7547-4-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0911-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034961770", 
          "https://doi.org/10.1007/s00125-007-0911-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0911-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034961770", 
          "https://doi.org/10.1007/s00125-007-0911-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0911-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034961770", 
          "https://doi.org/10.1007/s00125-007-0911-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.dsx.2008.04.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044362686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.5.1107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044445363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pcd.2009.07.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044575496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/phar.1168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047611116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-010-0020-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048097125", 
          "https://doi.org/10.1007/s12325-010-0020-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-010-0020-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048097125", 
          "https://doi.org/10.1007/s12325-010-0020-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Although glargine and detemir are both FDA-approved in the U.S. as long-acting insulin analogues, inherent differences in the insulins may lead to varying outcomes. This study examined changes in clinical measures and associated costs for veterans with type 2 diabetes on insulin therapy converted from insulin glargine to insulin detemir.\nMETHODS: A retrospective before-and-after comparison study was performed at a single-site medical center located in the southwestern U.S., comprising 133 Veterans diagnosed with type 2 diabetes receiving insulin therapy with glargine and converted to insulin detemir using a 1:1 unit dosage ratio. Patients' A1c, weight, body mass index, total daily dose, and estimated monthly insulin costs during and after conversion were compared employing Wilcoxon signed-rank tests. These measures were similarly assessed in patients at A1c goal (<7\u00a0%) prior to conversion.\nRESULTS: When switched from insulin glargine to insulin detemir, an increase in A1c (median of 7.7\u00a0% to 8.3\u00a0%, p\u2009<\u20090.01) and total daily dose (TDD: 40 to 46 units/day, p\u2009<\u20090.01) resulted. Monthly insulin costs decreased 19\u00a0% ($47 to $38, p\u2009<\u20090.01), or roughly a one-year savings of $110 per patient. An increase in A1c was similarly observed for patients at-goal prior to conversion but remained at-goal post-conversion (6.5\u00a0% to 6.7\u00a0%, p\u2009=\u20090.02).\nCONCLUSION: The increase in A1c and TDD following conversion from insulin glargine to insulin detemir suggests that glargine requires a smaller amount of units to reach the same glycemic-lowering ability compared to detemir. Despite the observed insulin cost savings associated with detemir, future studies should also determine overall costs (including indirect) and benefits associated with switching from glargine to detemir among Veteran with Type 2 diabetes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40200-015-0180-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1033289", 
        "issn": [
          "1726-7544", 
          "2251-6581"
        ], 
        "name": "Journal of Diabetes & Metabolic Disorders", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes", 
    "pagination": "53", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f4b95e4d0c158ac014c16d2f83d329b3391b9d972985d43613abb7fabefb3a07"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26120575"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101590741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40200-015-0180-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051373906"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40200-015-0180-z", 
      "https://app.dimensions.ai/details/publication/pub.1051373906"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88230_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs40200-015-0180-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40200-015-0180-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40200-015-0180-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40200-015-0180-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40200-015-0180-z'


 

This table displays all metadata directly associated to this object as RDF triples.

175 TRIPLES      21 PREDICATES      45 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40200-015-0180-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N692a310347e14697b455f1bbaf474f19
4 schema:citation sg:pub.10.1007/s00125-007-0911-x
5 sg:pub.10.1007/s12325-010-0020-y
6 sg:pub.10.1186/1478-7547-4-1
7 https://doi.org/10.1002/dmrr.989
8 https://doi.org/10.1002/phar.1168
9 https://doi.org/10.1016/j.clinthera.2008.11.001
10 https://doi.org/10.1016/j.clinthera.2009.03.005
11 https://doi.org/10.1016/j.dsx.2008.04.011
12 https://doi.org/10.1016/j.pcd.2009.07.001
13 https://doi.org/10.1046/j.1464-5491.2001.00546.x
14 https://doi.org/10.1111/j.1463-1326.2007.00756.x
15 https://doi.org/10.1155/2014/458104
16 https://doi.org/10.2147/dhps.s7301
17 https://doi.org/10.2337/dc08-9017
18 https://doi.org/10.2337/dc09-2294
19 https://doi.org/10.2337/diacare.28.5.1107
20 schema:datePublished 2015-12
21 schema:datePublishedReg 2015-12-01
22 schema:description BACKGROUND: Although glargine and detemir are both FDA-approved in the U.S. as long-acting insulin analogues, inherent differences in the insulins may lead to varying outcomes. This study examined changes in clinical measures and associated costs for veterans with type 2 diabetes on insulin therapy converted from insulin glargine to insulin detemir. METHODS: A retrospective before-and-after comparison study was performed at a single-site medical center located in the southwestern U.S., comprising 133 Veterans diagnosed with type 2 diabetes receiving insulin therapy with glargine and converted to insulin detemir using a 1:1 unit dosage ratio. Patients' A1c, weight, body mass index, total daily dose, and estimated monthly insulin costs during and after conversion were compared employing Wilcoxon signed-rank tests. These measures were similarly assessed in patients at A1c goal (<7 %) prior to conversion. RESULTS: When switched from insulin glargine to insulin detemir, an increase in A1c (median of 7.7 % to 8.3 %, p < 0.01) and total daily dose (TDD: 40 to 46 units/day, p < 0.01) resulted. Monthly insulin costs decreased 19 % ($47 to $38, p < 0.01), or roughly a one-year savings of $110 per patient. An increase in A1c was similarly observed for patients at-goal prior to conversion but remained at-goal post-conversion (6.5 % to 6.7 %, p = 0.02). CONCLUSION: The increase in A1c and TDD following conversion from insulin glargine to insulin detemir suggests that glargine requires a smaller amount of units to reach the same glycemic-lowering ability compared to detemir. Despite the observed insulin cost savings associated with detemir, future studies should also determine overall costs (including indirect) and benefits associated with switching from glargine to detemir among Veteran with Type 2 diabetes.
23 schema:genre research_article
24 schema:inLanguage en
25 schema:isAccessibleForFree true
26 schema:isPartOf N1487f4ed6e1141f2afe4b74a08c30e33
27 N17bd2ce07e5a44ed9f6186eae5214c1d
28 sg:journal.1033289
29 schema:name Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes
30 schema:pagination 53
31 schema:productId N26d5d042d41243b08e3e4319afd0481d
32 N3be7a10efa0f4418a41e6ca03aa04533
33 N43ba8776ddf54f19959d55120c263de7
34 Na5b2a604ca0d4fe98696ce3d5c64b324
35 Nc78d678adfa048f2ab535e8f9b1e1311
36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051373906
37 https://doi.org/10.1186/s40200-015-0180-z
38 schema:sdDatePublished 2019-04-11T13:08
39 schema:sdLicense https://scigraph.springernature.com/explorer/license/
40 schema:sdPublisher N1b0032f05a15485896a65e72c7994db7
41 schema:url http://link.springer.com/10.1186%2Fs40200-015-0180-z
42 sgo:license sg:explorer/license/
43 sgo:sdDataset articles
44 rdf:type schema:ScholarlyArticle
45 N06fd08e5842f45b1aa5fbb9145a1673f rdf:first N798634252ef44471b5d9e7ec4645603a
46 rdf:rest Nef43ea3d6b394f8e85f650a4cfa58db5
47 N07147e129633453a9f70f76c6f15ce0d rdf:first Na153b4be5e3a44d6894a3850f57769fd
48 rdf:rest N06fd08e5842f45b1aa5fbb9145a1673f
49 N1487f4ed6e1141f2afe4b74a08c30e33 schema:volumeNumber 14
50 rdf:type schema:PublicationVolume
51 N1544426528a84931a49dfe7902bce8a5 schema:affiliation https://www.grid.ac/institutes/grid.413775.3
52 schema:familyName Asias
53 schema:givenName Bernadette D.
54 rdf:type schema:Person
55 N16d436e70af14c27ab11f70df2023a37 rdf:first sg:person.0720325711.39
56 rdf:rest rdf:nil
57 N17bd2ce07e5a44ed9f6186eae5214c1d schema:issueNumber 1
58 rdf:type schema:PublicationIssue
59 N1b0032f05a15485896a65e72c7994db7 schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 N26d5d042d41243b08e3e4319afd0481d schema:name pubmed_id
62 schema:value 26120575
63 rdf:type schema:PropertyValue
64 N3770fa6d07974fd08c1ee2c1df5c5db4 rdf:first sg:person.01213255011.27
65 rdf:rest N07147e129633453a9f70f76c6f15ce0d
66 N3be7a10efa0f4418a41e6ca03aa04533 schema:name readcube_id
67 schema:value f4b95e4d0c158ac014c16d2f83d329b3391b9d972985d43613abb7fabefb3a07
68 rdf:type schema:PropertyValue
69 N43ba8776ddf54f19959d55120c263de7 schema:name dimensions_id
70 schema:value pub.1051373906
71 rdf:type schema:PropertyValue
72 N51195ca2d7b242a7b8f216b511ce7828 rdf:first Nc57bf734526e42c1829c899ec78adaa0
73 rdf:rest N3770fa6d07974fd08c1ee2c1df5c5db4
74 N5ac0b105bb2d47468f78d963ea598e77 schema:affiliation https://www.grid.ac/institutes/grid.413775.3
75 schema:familyName Cavness
76 schema:givenName Staci
77 rdf:type schema:Person
78 N692a310347e14697b455f1bbaf474f19 rdf:first N1544426528a84931a49dfe7902bce8a5
79 rdf:rest Nbd8b4ccae2e24dcc97c0d6a83ac6c3ae
80 N798634252ef44471b5d9e7ec4645603a schema:affiliation https://www.grid.ac/institutes/grid.413775.3
81 schema:familyName Krause
82 schema:givenName Jennifer D.
83 rdf:type schema:Person
84 Na153b4be5e3a44d6894a3850f57769fd schema:affiliation https://www.grid.ac/institutes/grid.413775.3
85 schema:familyName Patel
86 schema:givenName Jagruti R.
87 rdf:type schema:Person
88 Na5b2a604ca0d4fe98696ce3d5c64b324 schema:name nlm_unique_id
89 schema:value 101590741
90 rdf:type schema:PropertyValue
91 Nbd8b4ccae2e24dcc97c0d6a83ac6c3ae rdf:first sg:person.01051523326.95
92 rdf:rest N51195ca2d7b242a7b8f216b511ce7828
93 Nbee4272d0d314278a9feef8b3715299b rdf:first Neadf825de6c84bf3a9a1998750799ccb
94 rdf:rest N16d436e70af14c27ab11f70df2023a37
95 Nc57bf734526e42c1829c899ec78adaa0 schema:affiliation https://www.grid.ac/institutes/grid.413775.3
96 schema:familyName Small
97 schema:givenName Nancy L.
98 rdf:type schema:Person
99 Nc78d678adfa048f2ab535e8f9b1e1311 schema:name doi
100 schema:value 10.1186/s40200-015-0180-z
101 rdf:type schema:PropertyValue
102 Neadf825de6c84bf3a9a1998750799ccb schema:affiliation https://www.grid.ac/institutes/grid.413775.3
103 schema:familyName Dzenowski
104 schema:givenName Cassidy L.
105 rdf:type schema:Person
106 Nef43ea3d6b394f8e85f650a4cfa58db5 rdf:first N5ac0b105bb2d47468f78d963ea598e77
107 rdf:rest Nbee4272d0d314278a9feef8b3715299b
108 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
109 schema:name Medical and Health Sciences
110 rdf:type schema:DefinedTerm
111 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
112 schema:name Clinical Sciences
113 rdf:type schema:DefinedTerm
114 sg:journal.1033289 schema:issn 1726-7544
115 2251-6581
116 schema:name Journal of Diabetes & Metabolic Disorders
117 rdf:type schema:Periodical
118 sg:person.01051523326.95 schema:affiliation https://www.grid.ac/institutes/grid.416970.d
119 schema:familyName Stock
120 schema:givenName Eileen M.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051523326.95
122 rdf:type schema:Person
123 sg:person.01213255011.27 schema:affiliation https://www.grid.ac/institutes/grid.413775.3
124 schema:familyName Getchell
125 schema:givenName Katerine E.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213255011.27
127 rdf:type schema:Person
128 sg:person.0720325711.39 schema:affiliation https://www.grid.ac/institutes/grid.413775.3
129 schema:familyName Ta
130 schema:givenName Mia
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720325711.39
132 rdf:type schema:Person
133 sg:pub.10.1007/s00125-007-0911-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034961770
134 https://doi.org/10.1007/s00125-007-0911-x
135 rdf:type schema:CreativeWork
136 sg:pub.10.1007/s12325-010-0020-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1048097125
137 https://doi.org/10.1007/s12325-010-0020-y
138 rdf:type schema:CreativeWork
139 sg:pub.10.1186/1478-7547-4-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030421412
140 https://doi.org/10.1186/1478-7547-4-1
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1002/dmrr.989 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000421969
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1002/phar.1168 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047611116
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/j.clinthera.2008.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020313983
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/j.clinthera.2009.03.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014022709
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/j.dsx.2008.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044362686
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.pcd.2009.07.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044575496
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1046/j.1464-5491.2001.00546.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023578358
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1111/j.1463-1326.2007.00756.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012018782
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1155/2014/458104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026481274
159 rdf:type schema:CreativeWork
160 https://doi.org/10.2147/dhps.s7301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002672215
161 rdf:type schema:CreativeWork
162 https://doi.org/10.2337/dc08-9017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010475808
163 rdf:type schema:CreativeWork
164 https://doi.org/10.2337/dc09-2294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024449511
165 rdf:type schema:CreativeWork
166 https://doi.org/10.2337/diacare.28.5.1107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044445363
167 rdf:type schema:CreativeWork
168 https://www.grid.ac/institutes/grid.413775.3 schema:alternateName Central Texas Veterans Health Care System
169 schema:name Central Texas Veterans Health Care System, Department of Veterans Affairs, 76504, Temple, TX, USA
170 Department of Pharmacy Services, Memorial Hermann Health Care System – Texas Medical Center, 77030, Houston, TX, USA
171 rdf:type schema:Organization
172 https://www.grid.ac/institutes/grid.416970.d schema:alternateName Texas A&M Health Science Center
173 schema:name Center for Applied Health Research, Central Texas Veterans Health Care System in collaboration with Baylor Scott & White Health, 76502, Temple, TX, USA
174 Texas A&M Health Science Center, College of Medicine, 77807, Bryan, TX, USA
175 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...